| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Business Marketing Strategy Games: What Games are You Involved in? |
|
Just Other Articles - Business Marketing Strategy Games: What Games are You Involved in?
Sometimes I use games theory to help the owners of small businesses gain an insight into business behaviour. Often they start by denying any games are invo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product vled and we always have an enlightening discussion. There are three rough groups of games that I usually see played in business: Zero sum - I win, you l ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in oose The Zero Sum game is the common situation where one player's success reduces the returns for the others. Typically this happens anywhere where peo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ple compete in a limited market.
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe increase for any butcher reduces the sales made by the others. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro oods, our independent hardware store has been restricted to high-priced, low-volume lines. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y creamed off a lot of the 'pocket money' that the public used to put into charity donation boxes. For the Zero Sum Game, wherever the size of easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the cake is fixed, if I cut a big slice, you always get less. Unconditional contracts - we win or loose together Wherever people share goals t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hat lead to common outcomes, they can trade by swapping something that the other values.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ goods that I want to buy - we both benefit. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi - the MD, sales person and production worker need each other for the whole business to thrive. For Unconditional contracts, the size of the ca ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ke is elastic, and if we work together, we all get larger slices. Conditional positive sums - we choose how we win or loose The 'prisoners dile dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mma' is a sophisticated game with three possible outcomes - if I move, I do OK at your cost; if we both move, we lose together, but if we both hold fast, we cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin both maximise our benefits.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen remium of law-abiding drivers. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rs find, and without common management, the sea becomes over-fished. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ities that I know about. They can do the same for me. Where we both help each other, we both thrive. However if either of us feel we are doing all the givin y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products g without sufficient getting, we will drop out of the network. For Conditional positive sums, the size of the cake is determined by our coope . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ration and mutual trust, and selfish actions can damage everyone's livelihood. We all have market forces that control our freedom to pursue our busines elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s. If you identify which games are going on around you, you may gain sufficient insight to put yourself on the winning side as the game is played out tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|